MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $276,000 | -83.9% | 1,558 | -85.3% | 0.00% | -85.7% |
| Q2 2021 | $1,712,000 | -95.9% | 10,595 | -95.6% | 0.01% | -95.9% |
| Q1 2021 | $41,429,000 | -55.3% | 241,849 | -42.7% | 0.17% | -59.2% |
| Q4 2020 | $92,651,000 | +3346.8% | 421,832 | +2506.8% | 0.42% | +2382.4% |
| Q3 2020 | $2,688,000 | +4.3% | 16,182 | -51.7% | 0.02% | -15.0% |
| Q1 2020 | $2,577,000 | +26.9% | 33,529 | +70.1% | 0.02% | +53.8% |
| Q2 2019 | $2,030,000 | -93.3% | 19,708 | -97.0% | 0.01% | -87.6% |
| Q3 2018 | $30,502,000 | -23.1% | 647,586 | -19.5% | 0.10% | -53.1% |
| Q2 2018 | $39,675,000 | +317.2% | 804,776 | +159.8% | 0.22% | +366.7% |
| Q1 2018 | $9,510,000 | +4052.8% | 309,759 | +2367.4% | 0.05% | +4700.0% |
| Q4 2017 | $229,000 | -86.1% | 12,554 | -90.8% | 0.00% | -90.0% |
| Q3 2017 | $1,643,000 | – | 136,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |